Dedicated trial in women demonstrates the superiority of transcatheter vs. surgical aortic ...
TAVI was superior to surgical aortic valve replacement for reducing death, stroke, or rehospitalisation in women with severe aortic stenosis, according to the RHEIA trial. TAVI reduced rehospitalisations and offered shorter hospital stays, suggesting it could be the preferred treatment option for women with severe aortic stenosis.
Highlighted Terms
Related News
Clinical research on TAVR treatment for heart valve failure is praised, with Medtronic highlighting its positive outcomes for women and small aortic annuli patients. TAVR continues to show strong outcomes, with recent studies indicating reduced complications and comparable long-term results to SAVR for severe AS patients.
TAVI was superior to surgical aortic valve replacement for reducing death, stroke, or rehospitalisation in women with severe aortic stenosis, according to the RHEIA trial. TAVI reduced rehospitalisations and offered shorter hospital stays, suggesting it could be the preferred treatment option for women with severe aortic stenosis.